S. Reed - May 13, 2021 Form 4 Insider Report for Evoke Pharma Inc (EVOK)

Role
Director
Signature
/s/ Matthew J. D'Onofrio, Attorney-in-fact for Vickie S. Reed
Stock symbol
EVOK
Transactions as of
May 13, 2021
Transactions value $
$0
Form type
4
Date filed
5/17/2021, 09:05 PM
Next filing
Jan 6, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVOK Stock Option (Right to Buy) Award $0 +70K $0.00 70K May 13, 2021 Common Stock 70K $1.14 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on May 13, 2021 and shall vest in equal yearly installments over the three years following the grant date, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.